Several rat models of pulmonary hypertension have been developed. Howe
ver, up until now it has been difficult to monitor pulmonary arterial
pressure for long periods of time. The goal of the present study was t
o develop a telemetry system allowing chronic monitoring of pulmonary
arterial pressure in freely moving rats. For this purpose, while anima
ls were under anesthesia, a sensing catheter was implanted into the pu
lmonary arterial trunk through the right ventricle. This catheter was
connected to an emitter implanted in the abdomen. Validation of the sy
stem was performed in three steps. First, acutely, we controlled that
the pressure signal transmitted by the telemetry system was accurate a
nd corresponded to a signal obtained with a high-fidelity Millar cathe
ter. Second, we evaluated the chronic consequences of implantation of
the system. Third, we used the system to monitor pulmonary arterial pr
essure in a model of monocrotaline-induced hypertension in which the e
ffects of bosentan, an endothelin-receptor antagonist, were evaluated.
The telemetry system was reliable and did not lead to damage of the r
ight ventricle and/or to chronic pulmonary embolism. After a recovery
period of 8-10 days, mean pulmonary arterial pressure was stable. With
the use of this telemetry system, it was possible to follow the incre
ase of pulmonary arterial pressure induced by monocrotaline. In this m
odel, bosentan decreased mean pulmonary arterial pressure by 13% (P=0.
07), suggesting a role of endothelin in this model of pulmonary hypert
ension. We conclude that it is possible to use this telemetry system t
o monitor pulmonary arterial pressure in freely moving conscious rats.